Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. NVDA
3. RH
4. USO
5. SPCX
6. CRM
7. MH
8. RKLB
9. NDAQ
10. COGT

Go back to Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event
(NASDAQ: CVKD) Delayed: 4.03 --0 (-0%)
Previous Close $4.03    52 Week High $ 
Open $4.03    52 Week Low $ 
Day High $4.03    P/E N/A 
Day Low $4.03    EPS $ 
Volume 10,427